Content comparison of haemophilia specific patient-rated outcome measures with the international classification of functioning, disability and health (ICF, ICF-CY)

Health and Quality of Life Outcomes

Volumn 8, Issue , 2010, Pages

  Riva, Silvia ^a,b   Bullinger, Monika ^a   Amann, Edda ^c   von Mackensen, Sylvia ^a,b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FUNCTIONAL STATUS; HEMOPHILIA; HUMAN; INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH; MEDICAL RESEARCH; OUTCOME ASSESSMENT; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRE; SELF REPORT; TREATMENT PLANNING; WELLBEING; ADULT; CHILD; CLASSIFICATION; COMPARATIVE STUDY; FEMALE; HEMOPHILIA A; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ADULT; CHILD; FEMALE; HEMOPHILIA A; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; PATIENT SATISFACTION; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 78649322898     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-8-139     Document Type: Article

References (53)

1. World Federation of Hemophilia Global Report. 2001, World Federation of Hemophilia., http://www.wfh.org
2. White GC, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J. Factor VIII and Factor IX Subcommittee. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Journal of Thrombosis and Haemostasis 2001, 85:560.
3. Kern M, Blanchette V, Stain AM, Einarson TR, Feldman BM. Clinical and cost implications of target joints in Canadian boys with severe hemophilia. Am J Pediatr 2004, 145(5):628-634.
4. Mulder K, Llinás A. The target joint. Haemophilia 2004, 10(4):152-156. 10.1111/j.1365-2516.2004.00976.x, 15479389.
5. Mannucci PM. Hemophilia: treatment options in the twenty-first century. Journal of Thrombosis and Haemostasis 1:1349-1355. 10.1046/j.1538-7836.2003.00262.x, 12871268.
6. Ljung R. Second Workshop of the European Paediatric Network for Haemophilia Management, 17-19 September 1998 in Vitznau/Switzerland. Haemophilia 1999, 5(4):286-291. 10.1046/j.1365-2516.1999.00328.x, 10950622.
7. Berntorp E, Astermark J, Björkman S, Blanchette VS, Fischer K, Giangrande PL, Gringeri A, Ljung RC, Manco-Johnson MJ, Morfini M, Kilcoyne RF, Petrini P, Rodriguez-Merchan EC, Schramm W, Shapiro A, van den Berg HM, Hart C. Consensus perspectives on prophylactic therapy for haemophilia: summary statement. Haemophilia 2003, 9(1):1-4. 10.1046/j.1365-2516.9.s1.17.x, 12709030.
8. Hay CH. Prophylaxis in adults with haemophilia. Haemophilia 2007, 13(2):10-5.
9. Miners AH, Sabin CA, Tolley KH, Jenkinson C, Kind P, Lee CA. Assessing health-related quality-of-life in individuals with haemophilia. Haemophilia 1999, 5:378-385. 10.1046/j.1365-2516.1999.00347.x, 10583523.
10. Fischer K, Van der Bom JG, Van den Berg HM. Health-related quality of life as outcome parameter in haemophilia treatment. Haemophilia 2003, 9(1):75-82. 10.1046/j.1365-2516.9.s1.13.x, 12709041.
11. Scalone L, Mantovani LG, Mannucci PM, Gringeri A. The COCIS Study Investigators. Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors. Haemophilia 2006, 12(2):154-162. 10.1111/j.1365-2516.2006.01204.x, 16476090.
12. Gringeri A, Mantovani LG, Scalone L, Mannucci PM, . the COCIS Study Group Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group. Blood 2003, 102(7):2358-2363. 10.1182/blood-2003-03-0941, 12816859, the COCIS Study Group.
13. Beeton K. Evaluation of outcome of care in patients with haemophilia. Haemophilia 2002, 8(3):428-434. 10.1046/j.1365-2516.2002.00599.x, 12010445.
14. Gringeri A, Mantovani L, von Mackensen S. Quality of life assessment in clinical practice in haemophilia treatment. Haemophilia 2006, 12(3):1-8.
15. Marshall S, Haywood K, Fitzpatrick R. Impact of patient-reported outcome measures on routine practice: a structured review. Journal of Evaluation in Clinical Practice 2005, 12(5):559-568.
16. Revicki DA, Gnanasakthy A, Weinfurt K. Documenting the rationale and psychometric characteristics of patient reported outcomes for labelling and promotional claims: the PRO evidence dossier. Quality of Life Research 2007, 16(7):17-23.
17. Bullinger M, Globe D, Wasserman J, Young NL, von Mackensen S, . on behalf of the Health Related Quality of Life Expert Working Group of the International Prophylaxis Study Group (IPSG). Challenges of Patient-Reported Outcome Assessment in Haemophilia Care - a State of the Art Review. Value and Health 2009, 12(5):808-820. on behalf of the Health Related.
18. Cella DF, Tulsky DS. Measuring Quality of Life Today: Methodological Aspects. Oncology 1990, 4(5):29-38.
19. Bullinger M. Quality of life - definition, conceptualization and implications. A methodologists view. Theoretical Surgery 1991, 6:143-148.
20. Bullinger M, von Mackensen S, Fischer K, Khair K, Petersen C, Ravens-Sieberer U, Rocino A, Sagnier P, Tusell JM, van den Berg M, Vicariot M. Pilot testing of the Haemo-QoL quality of life questionnaire for haemophiliac children in six European countries. Haemophilia 2002, 8(2):47-54. 10.1046/j.1351-8216.2001.114.doc.x, 11966854.
21. von Mackensen S, Bullinger M, . the Haemo-QoL Group Development and testing of an instrument to assess the quality of life of children with haemophilia in Europe (Haemo-QoL). Haemophilia 2004, 10(Suppl. 1):17-25. 10.1111/j.1355-0691.2004.00875.x, 14987245, the Haemo-QoL Group.
22. Young N, Bradley C, Blanchette V, Wakefield C, Barnard D, McCusker P. Development of a health-related quality of life measure for boys with haemophilia: The Canadian Haemophilia Outcomes-Kids Life Assessment Tool (CHO-KLAT). Haemophilia 2004, 10(Suppl.1):34-43. 10.1111/j.1355-0691.2004.00877.x, 14987247.
23. Manco-Johnson M, Morrissey-Harding G, Edelman-Lewis B, Oster G, Larson P. Development and validation of a measure of disease-specific quality of life in young children with haemophilia. Haemophilia 2004, 10:34-41. 10.1046/j.1365-2516.2003.00842.x, 14962218.
24. Arranz P, Remor E, Quintana M, Villar A, Díaz JL, Moreno M, Monteagudo J, Ugarriza A, Soto I, Pérez R, Chacón J, García-Luaces M, Cid A, Balda I, López MF, Gutíerrez MJ, Martínez E, Marrero C, Prieto M, Sedano C, Vaca R, Altisent C, Hernández-Navarro F, . Hemofilia-QoL Group Development of a new disease-specific quality-of-life questionnaire to adults living with haemophilia. Haemophilia 2004, 10(4):376-82. 10.1111/j.1365-2516.2004.00918.x, 15230953, Hemofilia-QoL Group.
25. Rentz A, Flood E, Altisent C, Bullinger M, Klamroth R, Garrido PR, Scharrer I, Schramm W, Gorina E, . the members of the Steering committee of Haemo-Qol-A Cross-cultural development and psychometric evaluation of patient-reported health-related quality of life questionnaire for adults with haemophilia. Haemophilia 2008, 14:1023-1030. 10.1111/j.1365-2516.2008.01812.x, 18665853, the members of the Steering committee of Haemo-Qol-A.
26. von Mackensen S, Gringeri A, Ravera S, . the HAEM-A-QoL Group Validation of the haemophilia-specific quality of life questionnaire for adult patients with haemophilia (Haem-A-QoL). Haematologica 2005, 90(Suppl. 2):115-116. the HAEM-A-QoL Group.
27. von Mackensen S, Gringeri A. Quality of Life in Hemophilia. Handbook of Disease Burdens and Quality of Life Measure 2010, 4500. Springer, Heidelberg, Preedy VR, Watson RR, Chapter 215, Version: *eReference* (online access).
28. Weaver M, Patrick DL, Markson LE, Martin D, Frederic I, Berger M. Issues in the management of satisfaction with treatment. American Journal of Managed Care 1997, 3:579-594.
29. Revicki DA. Patient assessment of treatment satisfaction: methods and practical issues. GUT 2004, 53(4):40-44.
30. von Mackensen S, Gringeri A, Mantovani L, et al. Development and validation of the first treatment satisfaction scale for adult haemophiliacs (Hemo-SatA). Haemophilia 2004, 10(Suppl. 3):126. abstract.
31. Van Genderen FR, Van Meeteren NLU, Van der Bom JG. Functional consequences of haemophilia in adults: the development of the haemophilia activities list. Haemophilia 2004, 10:565-571. 10.1111/j.1365-2516.2004.01016.x, 15357785.
32. von Mackensen S, Czepa D, Herbsleb M, Hilberg T. Development and validation of a new questionnaire for the assessment of subjective physical performance in adult patients with haemophilia--the HEP-Test-Q. Haemophilia 2010, 16(1):170-8. Epub 2009 Oct 21, 10.1111/j.1365-2516.2009.02112.x, 19845778.
33. Cieza A, Brockow T, Ewert T, Amman E, Stucki G. Linking health-status measurements to the international classification of functioning, disability and health. Journal of Rehabilitation Medicine 2002, 34:205-210. 10.1080/165019702760279189, 12392234.
34. WHO, ICD-10 classification 2010, WHO, ICD-10 classification., http://www.who.int/classifications/icd/en/
35. World Health Organization International classification of functioning, disability and health. ICF. World Health Organization 2001, Geneva, World Health Organization.
36. World Health Organization International classification of impairments, disabilities and handicapps. World Health Organization 2001, Geneva, World Health Organization.
37. Simeonsson RJ, Hollenweger J, Lollar D, Martinuzzi A, Leonardi M, Bjorck-Akesson E. Applying the International Classification of Functioning, Disability and Health (ICF) to measure childhood disability. Disability and Rehabiitationl 2003, 3(17;25):602-610.
38. Lollar DJ, Simeonsson RJ. Diagnosis to function: classification for children and youths. Developmental and Behavioral Pediatrics 2005, 26:323-330.
39. World Health Organization International classification of functioning, disability, and health. Children and Youth Version ICF-CY. World Health Organization 2007, Switzerland, Geneva, World Health Organization.
40. Simeonson RJ, Lollar DJ, Hollowell J, Adams M. Revision of the international classification of impairments, disabilities and handicaps: developmental issues. Journal of Clinical Epidemiology 2000, 53:113-124. 10.1016/S0895-4356(99)00133-X, 10729683.
41. Ustun TB, Chatterji S, Bickenbach J, Kostanjsek N, Schneider M. The international classification of functioning, disability and health: A new tool for understanding disability and health. Disability and Rehabilitation 2003, 25(11):565-571. 10.1080/0963828031000137063, 12959329.
42. Khan F, Pallant J. Use of international classification of functioning, disabilityAnd health (icf) to describe patient-reported disability in multiple sclerosis and identification of relevant environmental factors. Journal of Rehabilitation Medicine 2007, 39:63-70. 10.2340/16501977-0002, 17225040.
43. Cieza A, Stucki G. Content comparison of health-related quality of life (HRQOL) instruments based on the international classification of functioning, disability and health (ICF). Quality of Life Research 2005, 14:1225-1237. 10.1007/s11136-004-4773-0, 16047499.
44. Marie Curie programme Marie Curie programme., http://www.murinet.eu
45. von Mackensen S, Scalone L, Ravera S, Mantovani L, Gringeri A, . the COCHE Study Group Assessment of health-related quality of life in patients with haemophilia with the newly developed haemophilia-specific instrument (Haem-A-QoL). Value and Health 2005, 8:A127. the COCHE Study Group.
46. The HEP-Test Project The HEP-Test Project., http://www.haemophilia-exercise.de
47. Cieza A, Geyh S, Chatterji S, Kostanjsek N, Ustun B, Stucki G. ICF linking rules: an update based on lessons learned. Journal of Rehabilitation Medicine 2005, 37(2):212-218. 10.1080/16501970510040263, 16024476.
48. Cohen J. A coefficient of agreement for nominal scales. Educational and Psychological Measurement 1960, 20:37-46.
49. Vierkant RAA. SAS macro for calculating bootstrapped confidence intervals about a kappa coefficient. SAS Users Group International Online Proceedings 2004, http://www2.sas.com/proceedings/sugi22/STATS/PAPER295.PDF
50. Vestling M, Tufvesson B, Iwarsson S. Indicators for return to work after stroke and the importance of work for subjective well-being and life satisfaction. Journal of Rehabilitation Medicine 2003, 35(3):127-131. 10.1080/16501970310010475, 12809195.
51. Gringeri A, von Mackensen S, Auerswald G, Bullinger M, Perrez garrido R, Kellermann E, Khair K, Lenk H, Vicario M, Villar S, Wermes C. Health status and health-related quality of life of children with haemophilia from six European countries. Haemophilia 2004, 10(suppl.1):26-33. 10.1111/j.1355-0691.2004.00876.x, 14987246.
52. Simeonsson RJ, Scarborough A, Hebbeler K. ICF and ICD codes provide a standard language of disability in young children. Journal of Clinical Epidemiology 2006, 59:365-373. 10.1016/j.jclinepi.2005.09.009, 16549258.
53. The Eschqol Project The Eschqol Project., http://www.eschqol.org